Christine Fox sold $327K of Teva Pharmaceutical Industries Limited (TEVA)

Executed Nov 20 2024, disclosed Nov 21 2024, 1 day later.

Value, as filed

$327K

19,388 sh × $16.87

Executed

Nov 20 2024

the trade date, as filed

Disclosed

Nov 21 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Christine Fox EVP, U.S. Commercial profile →

Christine Fox (EVP, U.S. Commercial) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $753K of TEVA (30,000 sh × $25.11, as filed), executed Nov 14 2025.

The name

TEVA

Teva Pharmaceutical Industries Limited TEVA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christine Fox in TEVA

TEVASALE Teva Pharmaceutical Industries Limited $751K
21,258 sh × $35.31
Exec Apr 30
Filed May 4 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $251K
7,924 sh × $31.67
Exec Mar 5
Filed Mar 9 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $295K
9,098 sh × $32.46
Exec Mar 4
Filed Mar 6 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $700K
28,229 sh × $24.78
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET TEVASALE Teva Pharmaceutical Industries Limited $753K
30,000 sh × $25.11
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET